Rating History for Day One Biopharmaceuticals (DAWN) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/11/2026 | Anupam Rama | Downgrade | Neutral (Overweight) |
21.50 (27.00) |
21.33 (21.53) |
0.94% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
